1-8 of 8
Shinichi Makita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Economic Burden Associated with ASCT in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Nationwide Health Insurance Claims Database Study in Japan during 2012-2022

Saaya Tsutsué, Shinichi Makita, Hiroya Asou, Shingo Wada, Wen Shi Lee, Dili Ainiwaer, Koki Idehara, Sona-Sanae Aoyagi, Seok-Won Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 2336.
https://doi.org/10.1182/blood-2023-173904
Published: 2023
Journal Articles

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

Clinical Trials & Observations
Koji Izutsu, Shinichi Makita, Kisato Nosaka, Makoto Yoshimitsu, Atae Utsunomiya, Shigeru Kusumoto, Satoko Morishima, Kunihiro Tsukasaki, Toyotaka Kawamata, Takaaki Ono, Shinya Rai, Hiroo Katsuya, Jun Ishikawa, Hironori Yamada, Kazunobu Kato, Masaya Tachibana, Yasuyuki Kakurai, Nobuaki Adachi, Kensei Tobinai, Kentaro Yonekura, Kenji Ishitsuka
Journal: Blood
Blood (2023) 141 (10): 1159–1168.
https://doi.org/10.1182/blood.2022016862
Published: 2023
Includes: Supplemental data
Journal Articles

Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)

Shinichi Makita, Shigeru Kusumoto, Jun-Ichi Tamaru, Hiroya Hashimoto, Akiko Miyagi Maeshima, Toshiki Uchida, Hideki Tsujimura, Eiichi Ohtsuka, Nobuyuki Takayama, Kayoko Murayama, Naoki Takahashi, Masahiro Yoshida, Hiroaki Morimoto, Yasuhiro Suzuki, Kazuyuki Shimada, Masanori Makita, Shuichi Ota, Hiroshi Gomyo, Hiroyuki Takahashi, Ritsuro Suzuki, Hiroo Katsuya, Hiro Tatetsu, Shuji Momose, Takahisa Yamashita, Kumiko Ohsawa, Naoko Asano, Dai Maruyama, Motoko Yamaguchi, Hirokazu Nagai
Journal: Blood
Blood (2022) 140 (Supplement 1): 11890–11892.
https://doi.org/10.1182/blood-2022-164977
Published: 2022
Journal Articles

Pivotal Phase 2 Study of the EZH1 and EZH2 Inhibitor Valemetostat Tosylate (DS-3201b) in Patients with Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma

Makoto Yoshimitsu, Koji Izutsu, Shinichi Makita, Kisato Nosaka, Atae Utsunomiya, Shigeru Kusumoto, Satoko Morishima, Kunihiro Tsukasaki, Toyotaka Kawamata, Takaaki Ono, Shinya Rai, Hiroo Katsuya, Jun Ishikawa, Hironori Yamada, Kazunobu Kato, Masaya Tachibana, Yasuyuki Kakurai, Nobuaki Adachi, Kensei Tobinai, Kentaro Yonekura, Kenji Ishitsuka
Journal: Blood
Blood (2021) 138 (Supplement 1): 303.
https://doi.org/10.1182/blood-2021-146657
Published: 2021
Journal Articles

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Shinichi Makita, Shigeru Kusumoto, Akiko Miyagi Maeshima, Hiroya Hashimoto, Hideki Tsujimura, Toshiki Uchida, Hiroaki Inoue, Eiichi Ohtsuka, Mitsutoshi Kurosawa, Nobuyuki Takayama, Eiju Negoro, Yasuhiro Suzuki, Junya Kuroda, Kayoko Murayama, Naoki Takahashi, Kazuyuki Shimada, Masataka Okamoto, Masanori Makita, Hiromi Iwasaki, Masahiro Yoshida, Naoko Asano, Jun-ichi Tamaru, Dai Maruyama, Motoko Yamaguchi, Hirokazu Nagai
Journal: Blood
Blood (2021) 138 (Supplement 1): 2451.
https://doi.org/10.1182/blood-2021-146340
Published: 2021
Journal Articles

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Tomotaka Suzuki, MD, Suguru Fukuhara, MD, Junko Nomoto, PhD, Satoshi Yamashita, PhD, Akiko Miyagi Maeshima, MD PhD, Yuta Ito, MD, Shunsuke Hatta, MD PhD, Sayako Yuda, MD PhD, Shinichi Makita, MD, PhD, Wataru Munakata, MD PhD, Tatsuya Suzuki, MD, PhD, Dai Maruyama, MD PhD, Hirokazu Taniguchi, MD, PhD, Toshikazu Ushijima, MD PhD, Koji Izutsu, MDPhD, Kensei Tobinai, MD PhD, Yukio Kobayashi, MDDSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 1571.
https://doi.org/10.1182/blood-2018-99-111262
Published: 2018
Journal Articles

First-in-Human Study of the EZH1/2 Dual Inhibitor DS-3201b in Patients with Relapsed or Refractory Non-Hodgkin Lymphomas — Preliminary Results

Dai Maruyama, MD PhD, Kensei Tobinai, MD PhD, Shinichi Makita, MD, PhD, Takashi Ishida, MD PhD, Shigeru Kusumoto, MD, Kenji Ishitsuka, MD PhD, Makoto Yoshimitsu, MD PhD, Yoshitaka Imaizumi, MD PhD, Yasushi Sawayama, MD, PhD, Shogo Takeuchi, MD, Atae Utsunomiya, MD, PhD, Kunihiro Tsukasaki, MD PhD, Sumiaki Fujitani, MSc, Kazushi Araki, D.V.M., PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4070.
https://doi.org/10.1182/blood.V130.Suppl_1.4070.4070
Published: 2017
Journal Articles

Impact of the Double Expression of MYC and BCL2 on Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma Following R-CHOP Chemoimmunotherapy

Tomotaka Suzuki, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Kinuko Tajima, Yuta Ito, MD, Shunsuke Hatta, MD PhD, Sayako Yuda, MD, PhD, Shinichi Makita, MD, PhD, Suguru Fukuhara, MD, Wataru Munakata, MD PhD, Tatsuya Suzuki, MD, PhD, Hirokazu Taniguchi, MD, Yukio Kobayashi, MD PhD, Koji Izutsu, MD, PhD, Kensei Tobinai, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2846.
https://doi.org/10.1182/blood.V130.Suppl_1.2846.2846
Published: 2017